SCHEMBL2456084

SCHEMBL2456084

COc1ccc2cc(-c3c[nH]cc3C(=O)O)ccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 1/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.55
▸ KDM4E B2RXH2 5/20 0.52
▸ ALDH1A1 P00352 5/20 0.52
▸ HPGD P15428 3/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52
▸ RELA Q04206 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ POLB P06746 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ HSD17B1 P14061 3/20 0.46
▸ HSD17B2 P37059 3/20 0.46
▸ PRKAB2 O43741 2/20 0.46
▸ PRKAG1 P54619 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15780703 0.81 KDM4E (0.64) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL3335325 0.77 KDM4E (0.56) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL27690279 0.76 SMN1; SMN2 (0.55) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL13828205 0.76 KDM4E (0.58) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL7532214 0.75 GSTP1 (0.62) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL1180172 0.75 KDM4E (0.53) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL27710303 0.74 SMN1; SMN2 (0.52) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL5042258 0.73 KDM4E (0.74) GSTP1KDM4EHSD17B1HSD17B2CA1
SCHEMBL14063326 0.73 KDM4E (0.79) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL2879060 0.72 KDM4E (0.57) GSTP1SMN1; SMN2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 — — US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET GSTP1 910/4885SMN1; SMN2 3462/4885KDM4E 4565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback